Susquehanna International Group’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $928 | Buy |
+37,102
| New | +$928 | ﹤0.01% | 6297 |
|
|
2024
Q4 | – | Sell |
-113,375
| Closed | -$5.44K | – | 6238 |
|
|
2024
Q3 | $5.44K | Sell |
113,375
-8,800
| -7% | -$422 | ﹤0.01% | 5488 |
|
|
2024
Q2 | $5.01K | Buy |
122,175
+44,117
| +57% | +$1.81K | ﹤0.01% | 5502 |
|
|
2024
Q1 | $4.29K | Sell |
78,058
-11,399
| -13% | -$627 | ﹤0.01% | 5402 |
|
|
2023
Q4 | $8.05K | Buy |
89,457
+21,617
| +32% | +$1.95K | ﹤0.01% | 5749 |
|
|
2023
Q3 | $6.45K | Sell |
67,840
-5,734
| -8% | -$545 | ﹤0.01% | 5362 |
|
|
2023
Q2 | $8.09K | Buy |
73,574
+6,238
| +9% | +$686 | ﹤0.01% | 5457 |
|
|
2023
Q1 | $8.48K | Buy |
67,336
+17,150
| +34% | +$2.16K | ﹤0.01% | 5739 |
|
|
2022
Q4 | $5.92K | Sell |
50,186
-14,714
| -23% | -$1.74K | ﹤0.01% | 5538 |
|
|
2022
Q3 | $9K | Buy |
64,900
+8,998
| +16% | +$1.25K | ﹤0.01% | 5838 |
|
|
2022
Q2 | $8K | Buy |
55,902
+6,672
| +14% | +$955 | ﹤0.01% | 5531 |
|
|
2022
Q1 | $7K | Buy |
49,230
+13,141
| +36% | +$1.87K | ﹤0.01% | 5583 |
|
|
2021
Q4 | $7K | Buy |
+36,089
| New | +$7K | ﹤0.01% | 5727 |
|
|
2020
Q4 | – | Sell |
-26,802
| Closed | -$10K | – | 4801 |
|
|
2020
Q3 | $10K | Sell |
26,802
-18
| -0.1% | -$7 | ﹤0.01% | 4329 |
|
|
2020
Q2 | $11K | Buy |
26,820
+13,952
| +108% | +$5.72K | ﹤0.01% | 4152 |
|
|
2020
Q1 | $6K | Buy |
+12,868
| New | +$6K | ﹤0.01% | 4449 |
|